NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $397,000 | 0.0% | 4,695 | 0.0% | 0.16% | 0.0% |
Q2 2022 | $397,000 | +58.2% | 4,695 | +63.8% | 0.16% | +75.6% |
Q1 2022 | $251,000 | 0.0% | 2,867 | 0.0% | 0.09% | 0.0% |
Q4 2021 | $251,000 | +4.1% | 2,867 | -2.6% | 0.09% | -10.9% |
Q3 2021 | $241,000 | -2.0% | 2,944 | +9.0% | 0.10% | -9.0% |
Q2 2021 | $246,000 | +6.5% | 2,701 | -0.0% | 0.11% | -5.1% |
Q1 2021 | $231,000 | -2.5% | 2,702 | +7.6% | 0.12% | -7.1% |
Q4 2020 | $237,000 | -14.4% | 2,512 | -21.0% | 0.13% | -28.4% |
Q3 2020 | $277,000 | +3.4% | 3,180 | +3.5% | 0.18% | -4.3% |
Q2 2020 | $268,000 | +17.0% | 3,073 | +10.9% | 0.18% | -13.6% |
Q1 2020 | $229,000 | -2.6% | 2,772 | +11.6% | 0.21% | +17.7% |
Q4 2019 | $235,000 | +10.8% | 2,483 | +1.8% | 0.18% | -3.7% |
Q3 2019 | $212,000 | -2.3% | 2,439 | +2.7% | 0.19% | -6.0% |
Q2 2019 | $217,000 | -8.1% | 2,374 | -3.3% | 0.20% | -14.5% |
Q1 2019 | $236,000 | +88.8% | 2,455 | +69.9% | 0.23% | +134.0% |
Q4 2018 | $125,000 | – | 1,445 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |